Follow
Charmaine Brown
Charmaine Brown
Verified email at uab.edu
Title
Cited by
Cited by
Year
Deleting DNMT3A in CAR T cells prevents exhaustion and enhances antitumor activity
B Prinzing, CC Zebley, CT Petersen, Y Fan, AA Anido, Z Yi, P Nguyen, ...
Science translational medicine 13 (620), eabh0272, 2021
1472021
CD19-CAR T cells undergo exhaustion DNA methylation programming in patients with acute lymphoblastic leukemia
CC Zebley, C Brown, T Mi, Y Fan, S Alli, S Boi, G Galletti, E Lugli, ...
Cell reports 37 (9), 2021
532021
Proinflammatory cytokines promote TET2-mediated DNA demethylation during CD8 T cell effector differentiation
CC Zebley, HA Abdelsamed, HE Ghoneim, S Alli, C Brown, D Haydar, ...
Cell reports 37 (2), 2021
172021
Detection of BRAF V600E Mutations With Next-Generation Sequencing in Infarcted Thyroid Carcinomas After Fine-Needle Aspiration
E Kouba, A Ford, CG Brown, C Yeh, GP Siegal, U Manne, IE Eltoum
American Journal of Clinical Pathology 150 (2), 177-185, 2018
62018
Sample preparation of circulating cell-free DNA by direct-on-specimen and silica-based methods
A Ford, C Brown, CH Yeh
J Biol Sci 3 (2), 23-35, 2017
42017
Fight for children left for the crows
C Brown, L Brown, A Ford, J Nisbet, M Sweet, A Donnellan, L Gruenwald
Dominion Sunday Times 29, 10, 1990
41990
High concordance in advanced cancer patient paired testing by commercially available tumor tissue NGS assays and a liquid biopsy NGS assay.
RC Arend, A Londono, A Martinez, A Ford, C Brown, CH Yeh, N Javadi, ...
Journal of Clinical Oncology 36 (15_suppl), e24169-e24169, 2018
22018
The evolution of in situ genetic technology
A Ford, C Brown, E Caver, CH Yeh
Journal of Clinical Research in Oncology 1 (1), 1-5, 2018
22018
Combining circulating stromal cells with cell free DNA for increased sensitivity in profiling oncogenic mutations and indicates highly aggressive non small cell lung cancer
DL Adams, SH Lin, A Raghavakaimal, G Weiss, A Ford, C Brown, CH Yeh
Cancer Res 79, 437, 2019
12019
Somatic Mutations in Cancer-Free Individuals: A Liquid Biopsy Connection
A Ford, C Brown, CH Yeh
12018
When liquid biopsy cell-free DNA meets with tissue biopsy RNA
A Ford, C Brown, CH Yeh
Biomed J Sci Tech Res 1, 256-257, 2017
12017
CD19-CAR T Cells Develop Exhaustion Epigenetic Programs During a Clinical Response
CC Zebley, C Brown, T Mi, Y Fan, S Alli, S Boi, G Galletti, E Lugli, ...
The Journal of Immunology 208 (1_Supplement), 122.04-122.04, 2022
2022
CD19-CAR T Cells Develop Exhaustion Epigenetic Programs during a Clinical Response
CC Zebley, C Brown, T Mi, Y Fan, S Alli, S Boi, G Galletti, E Lugli, ...
Blood 138 (Supplement 1), 2782-2782, 2021
2021
Simultaneous cell-free RNA PD-L1 expression and MSI from the same single-tube of blood in solid tumors
GJ Weiss, P Walker, D Aktas, A Ford, C Brown, CH Yeh, N Javadi
Cancer Research 79 (13_Supplement), 1368-1368, 2019
2019
Salvage genetic testing on buccal swab samples using liquid in situ amplification identifies genetic mutations from previous test failures
GJ Weiss, A Ford, C Brown, E Caver, M Vallejo, C Adeyemi, F Collins, ...
Cancer Research 79 (13_Supplement), 4227-4227, 2019
2019
Real world results of liquid biopsy in stage 3/4 solid tumors and potential''clinical actionability.
RC Arend, A Londono, A Martinez, A Ford, C Brown, CH Yeh, N Javadi, ...
Journal of Clinical Oncology 36 (15_suppl), 2555-2555, 2018
2018
BRAF V600E Mutations in Infarcted Thyroid Carcinoma
E Kouba, A Ford, CG Brown, C Yeh, HG Kim, GP Siegal, U Manne, ...
LABORATORY INVESTIGATION 97, 327A-327A, 2017
2017
Cancer patient paired congruence between a commercially available tumor tissue and a liquid biopsy NGS assays
GJ Weiss, A Ford, C Brown, CH Yeh, N Javadi
Breast 9, 24.3, 0
Real world results of liquid biopsy in stage 4 solid tumors and potential “clinical actionability”
GJ Weiss, A Ford, C Brown, CH Yeh, N Javadi
Breast 14, 18.7, 0
The system can't perform the operation now. Try again later.
Articles 1–19